pCDH-EF1-Nluc-P2A-copGFP-T2A-Puro Citations (2)

Originally described in: pCDH-EF1-Nluc-P2A-copGFP-T2A-Puro
Unpublished

Articles Citing pCDH-EF1-Nluc-P2A-copGFP-T2A-Puro

Articles
Targeting HLA-DR loss in hematologic malignancies with an inhibitory chimeric antigen receptor. Fei F, Rong L, Jiang N, Wayne AS, Xie J. Mol Ther. 2022 Mar 2;30(3):1215-1226. doi: 10.1016/j.ymthe.2021.11.013. Epub 2021 Nov 18. PubMed
Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer. Raftery MJ, Franzen AS, Radecke C, Boulifa A, Schonrich G, Stintzing S, Blohmer JU, Pecher G. Int J Mol Sci. 2023 May 20;24(10):9038. doi: 10.3390/ijms24109038. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.